ity than HCQ. In addition, CQ has both a prophylactic and a therapeutic advantage. Vincent et al. tested various concentrations of CQ (0.1–10 µM) added 20–24 h prior to SARS-CoV infection and found that 0.1, 1, and 10 µM CQ reduce